http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SG-10201912527X-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40765ca9a78b54a8a76f781d159ad145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f1ef6f1a6319f01bb92d09c61a4f0e76
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
filingDate 2011-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca75403227313f481a2571ad2dcd9989
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ebb63222f7640dd3babf3a2407eec9e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a5d7d300c750400e537bf50b7c8ad1a
publicationDate 2020-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber SG-10201912527X-A
titleOfInvention Therapeutic compositions comprising rilpivirine hcl and tenofovir disoproxil fumarate
priorityDate 2010-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6398764
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419475605
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6451164
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453266653

Total number of triples: 22.